Trials / Completed
CompletedNCT00321516
Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder
Effects of Aripiprazole on the Steady-State Pharmacokinetics of Lamotrigine in Subjects With Bipolar I Disorder
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (planned)
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this clinical research study is to learn if aripiprazole has a drug-drug interaction with lamotrigine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | aripiprazole | Tablets, Oral, 10, 20, or 30 mg (titrated), once daily, 14 days. |
Timeline
- Start date
- 2006-07-01
- Primary completion
- 2007-02-01
- Completion
- 2007-02-01
- First posted
- 2006-05-03
- Last updated
- 2013-11-08
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00321516. Inclusion in this directory is not an endorsement.